who should not take glp 1 medications GLP-1 have transformed the conversation around weight loss, but they're the right choice for everyone. Stanford Medicine endocrinologist Sun Kim, MD, MS, and bariatric and minimally invasive surgeon Dan Azagury GLP-1 medications may increase dehydration

5 Short-acting insulin regimens are an acceptable alternative, but they may require a change in frequency (i.e., from once daily to twice daily) to ensure adequate coverage

Numerous clinical and preclinical studies suggest that gut dysbiosis may contribute to epilepsy development [80, 81]

Recent studies have examined whether GLP-1 medications such as semaglutide might offer additional anti-inflammatory benefits beyond weight management

Preparing your injection Remove the reconstituted KLOW vial from refrigeration

Eligibility Criteria GLP-1 medications, including semaglutide and tirzepatide, are typically prescribed for adults with a BMI of 30 or higher, or 27+ with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol